4 Current news of Janssen Pharmaceutica

rss

Cenix BioScience Signs Collaboration and Technology License Agreement for In Vivo siRNA Delivery

05-06-2011

Cenix BioScience GmbH announced that, together with its new subsidiary, Cenix BioScience Belgium bvba, it has signed a Collaboration and Technology License Agreement with Janssen Research & Development, a division of Janssen Pharmaceutica NV, to improve the in vivo applicability of ...

more

Intana Announces Agreement to Provide Proprietary Spectroscopy Technology

07-15-2010

Intana Bioscience GmbH announced that it has entered an agreement with Johnson & Johnson Pharmaceutical Research & Development, a division of Janssen Pharmaceutica N.V., Beerse, Belgium. Under the agreement, Intana will provide its proprietary Fluorescent Cross Correlation Spectroscopy (FCCS) ...

more

Intana Announces Agreement to Provide Proprietary Spectroscopy Technology

07-07-2010

Intana Bioscience GmbH announced that it has entered an agreement with Johnson & Johnson Pharmaceutical Research & Development, a division of Janssen Pharmaceutica N.V., Beerse, Belgium. Under the agreement, Intana will provide its proprietary Fluorescent Cross Correlation Spectroscopy (FCCS) ...

more

PamGene Platform Adopted for Kinase Drug R&D Program

Collaboration with Johnson & Johnson Pharmaceutical Research & Development

03-13-2006

PamGene International BV and Johnson & Johnson Pharmaceutical Research & Development (J&JPRD), a division of Janssen Pharmaceutica NV have announced significant progress in their kinase profiling collaboration. After extensive evaluation, PamGene's microarray-based biochemical kinase activity ...

more

Page 1 From 1
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE